arrow
S

Susanne Bogers

erasmus university
H指数:19
被引数:2,445

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterisation of immune responses targeting highly pathogenic avian influenza A(H5) viruses in health-care workers in the Netherlands: an observational, cross-sectional analysis

针对荷兰医疗保健工作者中针对高致病性禽流感A(H5)病毒的免疫反应特征:一项观察性横断面分析

2026-04-130
OAAI
Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination

单价XBB.1.5疫苗接种优先增强SARS-CoV-2 Omicron谱系特异性免疫反应

2026-01-080
OAAI
Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up study

荷兰基于CD4+ T细胞计数分层评估HIV感染者COVID-19疫苗免疫原性的纵向研究:一项为期两年的随访研究

2025-05-190
OA
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

原始新型冠状病毒肺炎启动方案影响二价BA.1和BA.5加强剂的免疫原性

2024-05-185
OAAI
Clinical and Virological Outcome of Monoclonal Antibody Therapies Across Severe Acute Respiratory Syndrome Coronavirus 2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study

245例免疫功能低下患者新型冠状病毒变异单克隆抗体治疗的临床和病毒学结果: 一项多中心前瞻性队列研究

2024-03-065
OAAI
Humoral and cellular immune responses after COVID-19 vaccination of lung transplant recipients and patients on the waiting list: a 6-month follow-up

肺移植受者和等待名单上的患者新型冠状病毒肺炎疫苗接种后的体液和细胞免疫反应: 6个月的随访

2024-01-040
OAAI
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial
2023-08-0120
OAAI
Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses
2023-05-172
OAAI
Original Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial
2023-02-0119
OAAI
Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol
2022-11-296
OAAI
Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination
2022-11-1911
OAAI
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study
2022-10-2731
OAAI
Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals
2022-10-18130
OAAI
Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers
2022-07-1510
OAAI